EichorEICHOR
Condition: Neoplasms Ovarian Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Neoplasms Ovarian

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Ad
Phase 1 · 20 location(s) · TerSera Therapeutics LLC · NCT07310420A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Phase 1 · 9 location(s) · Avacta Life Sciences Ltd · NCT04969835A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Su
Phase 1 · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT07069335Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expre
Phase 3 · 208 location(s) · Daiichi Sankyo · NCT06819007An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Phase 2 · 6 location(s) · University of Colorado, Denver · NCT05887609A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients
Phase N/A · 4 location(s) · West China Hospital · NCT04716257Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Onc
NA · 13 location(s) · Centre Francois Baclesse · NCT06553612ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Phase N/A · 57 location(s) · Guardant Health, Inc. · NCT05059444Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer
Phase 1 · 1 location(s) · Tongji Hospital · NCT05684731Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Phase 1 · 18 location(s) · Duke Street Bio Ltd · NCT06458712Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · 629 location(s) · Children's Oncology Group · NCT03067181Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Development and Management of Registry in Patients With Gynecologic Cancer in Korea
Phase N/A · 1 location(s) · Asan Medical Center · NCT05912972Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
NA · 17 location(s) · Hospices Civils de Lyon · NCT03787056Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
Phase 1 · 1 location(s) · PhotonPharma, Inc. · NCT06366490Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
Phase 2 · 14 location(s) · MedSIR · NCT06180356A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol
Phase 3 · 1 location(s) · tongweihua · NCT07544030A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Phase 1/Phase 2 · 26 location(s) · Day One Biopharmaceuticals, Inc. · NCT05377996PEPPI Study: Identification of Women at Risk for Placental Dysfunction
Phase N/A · 1 location(s) · Oulu University Hospital · NCT06115122Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy fo
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07270679Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
Phase 2 · 6 location(s) · Canadian Cancer Trials Group · NCT04918186Hyperandrogenemia and Altered Day-night LH Pulse Patterns
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT03068910Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Phase 1/Phase 2 · 24 location(s) · Evopoint Biosciences Inc. · NCT06799637Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07480954IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
Phase N/A · 6 location(s) · Peter MacCallum Cancer Centre, Australia · NCT07138222Timing of LNG-IUD Insertion and Ovarian Cyst Formation
Phase N/A · 1 location(s) · Gaziosmanpasa Research and Education Hospital · NCT07248553Survival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinoma
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07540403Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 · 1 location(s) · University of California, Irvine · NCT06580002Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TRO
Phase 2 · 96 location(s) · AstraZeneca · NCT05489211Functional Proteins in Polycystic Ovary Syndrome
Phase N/A · 1 location(s) · Jagiellonian University · NCT06793098
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.